VanEck Biotech ETF - USD Stock

ETF

BBH

US92189F7261

Market Closed - Nasdaq 04:15:00 2024-04-25 pm EDT 5-day change 1st Jan Change
154.8 USD -1.63% Intraday chart for VanEck Biotech ETF - USD +1.15% -6.38%
Dynamic Chart

Investment objective

VanEck Vectors® Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.
Name
Price
Change
5d. change
1st Jan change
Weight
269.4 USD -1.33%+2.52%-6.47%19.50%
397.7 USD -0.76%+1.07%-2.26%11.25%
65.27 USD -2.70%-1.35%-19.43%9.94%
890.7 USD -1.75%-0.37%+1.41%8.97%
106.2 USD -2.45%+4.10%+6.77%5.32%
234 USD -2.85%+3.00%+1.12%4.71%
202.5 USD +0.23%+6.27%-21.76%4.58%
300.1 USD -3.02%+2.83%+6.01%4.00%
121 USD -1.48%+3.74%-13.06%3.79%
See all (23)
In partnership with
TrackInsight
Date Price Change Volume
24-04-25 154.8 -1.63% 53,720
24-04-24 157.3 +0.11% 6,140
24-04-23 157.2 +1.66% 6,412
24-04-22 154.6 +1.46% 3,558
24-04-19 152.4 +0.24% 6,343

Delayed Quote Nasdaq

Last update April 25, 2024 at 04:15 pm EDT

More quotes

ETF Ratings

Description

US92189F7261
Total Expense Ratio 0.35%
Asset Class
Sector
Size
Currency
Provider
Underlying MVIS US Listed Biotech 25 Net Total Return Index - USD

Features and characteristics

Jurisdiction
Fund Structure
Replication Method
Replication Model
Date of creation
2011-12-19
Dividend Policy
Geographical Focus

Distribution

Retail investor

AuM evolution ( 2024-03-27 )

AuM (EUR) 419 M€
AuM 1M 424 M€
AuM 3 months 444 M€
AuM 6 months 427 M€
AuM 12 months 450 M€